Package-Ref? Colorectal cancer SDC2/Septin 9 for Methylation control
CBPE0402
詢(xún) 價(jià)
索取COA
產(chǎn)品描述
產(chǎn)品數據庫
| Introduction | ||||||
| Description | DNA methylation is an epigenetic modification, a form of chemical modification of DNA, which refers to the carbon 5 of cytosine in the genomic CpG dinucleotide under the action of DNA methyltransferase. covalently bonded to a methyl group. It can change genetic expression without changing the DNA sequence. This package contains multiple detection samples for Colorectal cancer, We use simulated clinical cell lines to prepare them. If you are testing SDC2/Septin 9, you can choose this product. |
|||||
| Technical Data | ||||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
|
質(zhì)控品 |
CBPE0402-1 | 結直腸癌-SDC2,Septin9陽(yáng)性甲基化 | SDC2 Methylation with Positive control | Chr8:97506434-97506502(hg19) | N/A | |
| Septin9 Methylation with Positive control | Chr17:75369001-75369079(hg19) | N/A | ||||
| CBPE0402-2 | 結直腸癌-SDC2,Septin9陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
| CBPE0402-3 | 結直腸癌-SDC2陰性甲基化，Septin9陽(yáng)性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | 0.71% | ||
| Septin9 Methylation with Positive control | Chr17:75369001-75369079(hg19) | 95.21% | ||||
| CBPE0402-4 | 結直腸癌-Septin9陰性甲基化，SDC2陽(yáng)性甲基化 | SDC2 Methylation with Positive control | Chr8:97506434-97506502(hg19) | 69.82% | ||
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | 0.56% | ||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
| 單陽(yáng)SDC2-參考品 |
單陽(yáng)SDC2 區段-強陽(yáng)性參考品-1 |
CBPE0402-5 | SDC2強陽(yáng)性甲基化參考品，Septin9陰性甲基化 | SDC2 Methylation Reference Standard with 65.00% | Chr8:97506434-97506502(hg19) | 69.82% |
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | 0.56% | ||||
|
單陽(yáng)SDC2 區段-強陽(yáng)性參考品-2 |
CBPE0402-6 | SDC2強陽(yáng)性甲基化參考品，Septin9陰性甲基化 | SDC2 Methylation Reference Standard with 10.00% | Chr8:97506434-97506502(hg19) | 9.91% | |
| Septin9 Methylation Negative Reference Standard | Chr17:75369001-75369079(hg19) | N/A | ||||
|
單陽(yáng)SDC2 區段-弱陽(yáng)性參考品 |
CBPE0402-7 | SDC2弱陽(yáng)性甲基化參考品，Septin9陰性甲基化 | SDC2 Methylation Reference Standard with 3.00% | Chr8:97506434-97506502(hg19) | N/A | |
| Septin9 Methylation Negative Reference Standard | Chr17:75369001-75369079(hg19) | N/A | ||||
|
單陽(yáng)SDC2 區段-檢測限參考品 |
CBPE0402-8 | SDC2檢測限甲基化參考品，Septin9陰性甲基化 | SDC2 Methylation Reference Standard with 1.00% | Chr8:97506434-97506502(hg19) | 1.20% | |
| Septin9 Methylation Negative Reference Standard | Chr17:75369001-75369079(hg19) | N/A | ||||
|
單陽(yáng)SDC2 區段-陰性參考品 |
CBPE0402-9 | 結直腸癌-SDC2,Septin9陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | |
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
|
單陽(yáng)SDC2 區段-精密度參考品 |
CBPE0402-10 | SDC2弱陽(yáng)性甲基化參考品，Septin9陰性甲基化 | SDC2 Methylation Reference Standard with 3.00% | Chr8:97506434-97506502(hg19) | N/A | |
| Septin9 Methylation Negative Reference Standard | Chr17:75369001-75369079(hg19) | N/A | ||||
| CBPE0402-11 | 結直腸癌-SDC2,Septin9陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
| Classification | Cat No. | Name | Description | Region | Methylation level | |
| 單陽(yáng)Septin9-參考品 |
單陽(yáng)Septin9 區段-強陽(yáng)性參考品-1 |
CBPE0402-12 | Septin9強陽(yáng)性甲基化參考品，SDC2陰性甲基化 | Septin9 Methylation Reference Standard with 90.00% | Chr17:75369001-75369079(hg19) | 95.21% |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | 0.71% | ||||
|
單陽(yáng)Septin9 區段-強陽(yáng)性參考品-2 |
CBPE0402-13 | Septin9強陽(yáng)性甲基化參考品，SDC2陰性甲基化 | Septin9 Methylation Reference Standard with 10.00% | Chr17:75369001-75369079(hg19) | 10.90% | |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
|
單陽(yáng)Septin9 區段-弱陽(yáng)性參考品 |
CBPE0402-14 | Septin9弱陽(yáng)性甲基化參考品，SDC2陰性甲基化 | Septin9 Methylation Reference Standard with 3.00% | Chr17:75369001-75369079(hg19) | N/A | |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
|
單陽(yáng)Septin9 區段-檢測限參考品 |
CBPE0402-15 | Septin9檢測限甲基化參考品，SDC2陰性甲基化 | Septin9 Methylation Reference Standard with 1.00% | Chr17:75369001-75369079(hg19) | 1.36% | |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
|
單陽(yáng)Septin9 區段-陰性參考品 |
CBPE0402-16 | 結直腸癌-SDC2,Septin9陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | |
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
|
單陽(yáng)Septin9 區段-精密度參考品 |
CBPE0402-17 | Septin9弱陽(yáng)性甲基化參考品，SDC2陰性甲基化 | Septin9 Methylation Reference Standard with 3.00% | Chr17:75369001-75369079(hg19) | N/A | |
| SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||||
| CBPE0402-18 | 結直腸癌-SDC2,Septin9陰性甲基化 | SDC2 Methylation with Negative control | Chr8:97506434-97506502(hg19) | N/A | ||
| Septin9 Methylation with Negative control | Chr17:75369001-75369079(hg19) | N/A | ||||
| 備注 | 1. 質(zhì)控品也叫準確度標準品，用于定性判斷； 2. 參考品用于定性和定量的判斷，其中強陽(yáng)、弱陽(yáng)、檢測限、精密度、特異性的判定需要視具體項目而定，本產(chǎn)品的判定僅為內部標準； 3. 質(zhì)控品用于性能評價(jià)，出廠(chǎng)檢，試劑盒日常檢測判定，參考品用于性能評價(jià)，出廠(chǎng)檢； 4.上述產(chǎn)品只展示了部分結果，甲基化程度可以定制。 |
|||||
| Product Information | ||||||
| Intended Use | Research Use Only | |||||
| Concentration | Download for COA | |||||
| Purity | Download for COA | |||||
| DNA electrophoresis | Download for COA | |||||
| Format | Genomic DNA | |||||
| Unit Size | 1ug | |||||
| Storage | 2-8°C | |||||
| Expiry | 36 months from the date of manufacture | |||||
| Remark | The data in the instruction manual is the data of a single test, and the specific data of each batch is subject to delivery. | |||||
